Desteia (formerly Auba) | $8,000,000 | (Feb 5, 2025)
Tandem | $6,100,000 | (Feb 5, 2025)
StackAdapt | $235,000,000 | (Feb 5, 2025)
Certified by Founder
Lodge
Myricx Bio
start up
United Kingdom
- London
- 09/07/2024
- Series A
- $115,246,800
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.
- Industry Biotechnology Research
- Website https://myricxbio.com/
- LinkedIn https://www.linkedin.com/company/myricx-pharma-ltd/
Qount | $17,000,000 | (Feb 5, 2025)
Trayd: Construction Payroll | $4,500,000 | (Feb 5, 2025)
hallo theo | $10,383,730 | (Feb 5, 2025)
Atombeam Technologies | $20,000,000 | (Feb 5, 2025)
INFI | $12,000,000 | (Feb 5, 2025)
Tana | $14,000,000 | (Feb 4, 2025)
Fimple | $12,000,000 | (Feb 4, 2025)
Akribion Therapeutics | $8,275,080 | (Feb 4, 2025)
Hidden Level Inc. | $65,000,000 | (Feb 4, 2025)